[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369650-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-369650-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","clinical-predictors-of-inherited-breast-cancer-at-a-comprehensive-cancer-centre-in-oman-is-it-time-for-universal-germline-genetic-testing","Clinical Predictors of Inherited Breast Cancer at a Comprehensive Cancer Centre in Oman: Is it time for universal germline genetic testing?","","Objectives: Explore clinical, histopathological and demographic characteristics of female Omani breast cancer patients to identify predictors of a positive germline genetic testing result, and assess the applicability of NCCN guidelines for risk assessment. Methods: Conducted at Sultan Qaboos Comprehensive Cancer Centre between Sept 2021 and Sept 2022; analyzed age, stage, metastasis, receptor status, Ki-67, histology, family history and NCCN applicability using logistic regression. Results: No significant baseline differences between positive and negative groups except family history; age had limited screening performance. Conclusions: Strict NCCN criteria may underdiagnose hereditary breast cancer; universal testing may be suitable with cost-effectiveness and appropriate methods.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-predictors-of-inherited-breast-cancer-at-a-comprehensive-cancer-centre-in-oman-is-it-time-for-universal-germline-genetic-testing/369650/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-predictors-of-inherited-breast-cancer-at-a-comprehensive-cancer-centre-in-oman-is-it-time-for-universal-germline-genetic-testing/369650.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective?","Question",{"text":63,"@type":64},"The study aimed to identify clinical and demographic predictors of a positive germline genetic testing result in female Omani breast cancer patients and to evaluate whether NCCN guidelines fit for risk assessment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What methods and variables were used to identify predictors?",{"text":68,"@type":64},"Data were collected from electronic patient files and family pedigrees, and logistic regression was used. Examined variables included age, disease stage, metastasis at diagnosis, hormone receptor and HER2 status, histopathology, Ki-67, and family history, plus NCCN guideline applicability.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about age as a screening tool?",{"text":72,"@type":64},"Age showed limited usefulness for distinguishing positive versus negative genetic testing results, indicated by an area under the ROC curve of 0.67.",{"name":74,"@type":61,"acceptedAnswer":75},"What are the implications for genetic testing in Oman?",{"text":76,"@type":64},"Applying NCCN testing criteria strictly may lead to underdiagnosis of hereditary breast cancer. Universal testing of breast cancer patients could be appropriate for Omani individuals, with careful attention to cost-effectiveness and testing methods.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},369650,1790386645,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":122,"preview_page_count":22,"preview_urls":149},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","SULTAN QABOOS UNIVERSITY MEDICAL JOURNAL 2025;25:341–348 Scan the QR to view  \nthe full-text article on the journal website  \nORIGINAL STUDY  \nClinical Predictors of Inherited Breast Cancer at a Comprehensive Cancer Centre in Oman: Is it time for universal germline genetic testing?  \nReem Abdulrahim a,*, Hasan Al-Sayegh b, Sara Al-Kiyumi a, Ilse Crous a, Khalid Al Baimani c, Adil Aljarrah d, Chantel Van Wyk a, Abeer Alsayegh a  \na Department of Genomics, Sultan Qaboos Comprehensive Cancer Centre, University Medical City, Muscat, Oman b Department of Clinical Research, Sultan Qaboos Comprehensive Cancer Centre, University Medical City, Muscat, Oman c Department of Medical Oncology, Sultan Qaboos Comprehensive Cancer Centre, University Medical City, Muscat, Omand Department of Surgical Oncology, Sultan Qaboos Comprehensive Cancer Centre, University Medical City, Muscat, Oman  \nAdvances in Knowledge  \n• The clinical characteristics of breast cancer patients may not eﬀectively enhance the yield of germline genetic testing.  \n• Age was found to be a poor screening tool for diﬀerentiating between positive and negative breast cancer patients.  \nApplications to Patient Care  \n• Study results will help in identifying more patients with pathogenic/likely pathogenic variants in cancer related genes that will help in optimizing patients care through targeted therapy and early detection of at-risk family members.  \n• Early detection of breast cancer in asymptomatic pathogenic/likely pathogenic variant carriers can signiﬁcantly improve prognosis and disease outcomes.  \n• The identiﬁcation of high-risk individuals will complement the early detection eﬀorts ofthe national breast cancer screening program.  \nABSTRACT  \nObjectives: This study aimed to explore the clinical, histopathological and demographic characteristics of female Omani breast cancer (BC) patients to identify possible predictors of a positive test result. Additionally, it aimed to evaluate the applicability of the National Comprehensive Cancer Network (NCCN) guidelines for germline genetic testing in risk assessment. Methods: This study was conducted at the Sultan Qaboos Comprehensive Cancer Centre, Oman, between September 2021 and September 2022. The variables examined included age, disease stage, presence of metastasis at diagnosis, hormone receptor status, human epidermal growth factor receptor 2 status, histopathological type, Ki-67 levels, family history of cancer (presence/absence) and the applicability of NCCN guidelines. Data were retrieved and summarised using electronic patient ﬁles and family pedigrees collected by geneticists and genetic counsellors. Logistic regression analysis was used to identify predictors of a positive test result. Results: Except forage, there were no statistically signiﬁcant diﬀerences in the baseline characteristics between patients with positive and negative genetic testing results. Furthermore, age was found to be a poor screening tool for diﬀerentiating between positive and negative patients, as indicated by an area under the receiver operating characteristic curve of 0.67. Conclusions: A strict application of the NCCN testing criteria in Omani BC patients may lead to underdiagnosis of hereditary BC. Universal testing of all BC patients could be appropriate for Omani individuals with BC, provided that careful consideration is given to cost-eﬀectiveness and the testing methods employed.  \nKeywords: Inherited; Breast Cancer; Guidelines; Predictors; Oman  \nReceived 22 July 2024; revised 25 October 2024; accepted 12 November 2024.  \nAvailable online 16 May 2025  \n* Corresponding author.  \nE-mail address: [reem.8383@gmail.com](reem.8383@gmail.com) (R. Abdulrahim).  \n[https://doi.org/10.18295/2075-0528.2843](https://doi.org/10.18295/2075-0528.2843)  \n2075- 0528/© 2025 Published by Sultan Qaboos University Sultan Qaboos University Medical Journal. This is an open-access article under the CC BY-ND license ([https://creativecommons.org/licenses/by","cbCailHBuk1ABMuY","https://ap.wps.com/l/cbCailHBuk1ABMuY","pdf",486604,"English","# Introduction\n## Study background and rationale\n# Methods\n## Study setting and study period\n## Variables and statistical analysis\n# Results\n## Baseline characteristics and screening performance\n# Conclusions","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"The study aimed to identify clinical and demographic predictors of a positive germline genetic testing result in female Omani breast cancer patients and to evaluate whether NCCN guidelines fit for risk assessment.\"},{\"question\":\"What methods and variables were used to identify predictors?\",\"answer\":\"Data were collected from electronic patient files and family pedigrees, and logistic regression was used. Examined variables included age, disease stage, metastasis at diagnosis, hormone receptor and HER2 status, histopathology, Ki-67, and family history, plus NCCN guideline applicability.\"},{\"question\":\"What did the study find about age as a screening tool?\",\"answer\":\"Age showed limited usefulness for distinguishing positive versus negative genetic testing results, indicated by an area under the ROC curve of 0.67.\"},{\"question\":\"What are the implications for genetic testing in Oman?\",\"answer\":\"Applying NCCN testing criteria strictly may lead to underdiagnosis of hereditary breast cancer. Universal testing of breast cancer patients could be appropriate for Omani individuals, with careful attention to cost-effectiveness and testing methods.\"}]","Clinical Predictors of Inherited Breast Cancer at a Comprehensive Cancer Centre in Oman: Is it time for universal germline genetic testing? | PDF",1790183894,[150],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/fef9a772967c7672d6e6bfcd09fb77af.webp",983,1310]